| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BCP.2008.07.009 |
| P698 | PubMed publication ID | 18692027 |
| P50 | author | Dieter Steinhilber | Q1222879 |
| Sabine Groesch | Q61597520 | ||
| Oliver Werz | Q64750706 | ||
| P2093 | author name string | Gerd Geisslinger | |
| Ronald Schmidt | |||
| Lars Tausch | |||
| Carlo Angioni | |||
| Carlo Pergola | |||
| Julia Metzner | |||
| Thorsten J Maier | |||
| Ovidiu Coste | |||
| Michael Hoernig | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 862-872 | |
| P577 | publication date | 2008-07-19 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Celecoxib inhibits 5-lipoxygenase | |
| P478 | volume | 76 |
| Q39652841 | 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity |
| Q37697795 | 5-Lipoxygenase inhibitors: a review of recent developments and patents |
| Q38100199 | 5-Lipoxygenase inhibitors: a review of recent patents (2010-2012). |
| Q51740191 | A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug. |
| Q42927254 | Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide |
| Q38665189 | Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males |
| Q38991781 | COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib |
| Q34437996 | CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide |
| Q28534569 | Cell survival signalling through PPARδ and arachidonic acid metabolites in neuroblastoma |
| Q39819038 | Cellular membranes function as a storage compartment for celecoxib |
| Q34847583 | Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib |
| Q38723598 | Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase. |
| Q37995534 | Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke |
| Q34610283 | Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis |
| Q38135433 | Inhibitors of the arachidonic acid cascade: interfering with multiple pathways |
| Q99711250 | Leukotrienes in Tumor-Associated Inflammation |
| Q40939320 | Liquid Chromatography-Mass Spectrometry-Based In Vitro Metabolic Profiling Reveals Altered Enzyme Expressions in Eicosanoid Metabolism. |
| Q57018870 | Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization |
| Q27000132 | Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies |
| Q34938495 | Naproxen induces type X collagen expression in human bone-marrow-derived mesenchymal stem cells through the upregulation of 5-lipoxygenase |
| Q38737298 | New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study. |
| Q38558587 | Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety |
| Q36047526 | PTGS-2-PTGER2/4 signaling pathway partially protects from diabetogenic toxicity of streptozotocin in mice |
| Q39906264 | Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis |
| Q37631485 | R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4. |
| Q39645747 | Role of leukotriene B4 in celecoxib-mediated anticancer effect |
| Q39150746 | Structure-activity relationship and in vitro pharmacological evaluation of imidazo[1,2-a]pyridine-based inhibitors of 5-LO. |
| Q34878474 | Studies on tracheorelaxant and anti-inflammatory activities of rhizomes of Polygonatum verticillatum |
| Q34616021 | Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations |
| Q35762636 | Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase |
| Q37636897 | The safety, pharmacokinetics, and efficacy of intraocular celecoxib |
| Q51766344 | Triterpene Acids from Frankincense and Semi-Synthetic Derivatives That Inhibit 5-Lipoxygenase and Cathepsin G. |
Search more.